FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

25806011000001102: Ebesque XL 400mg tablets (DB Ashbourne Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 17-Sep 2014. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
83064901000001113 Ebesque XL 400mg tablets (DB Ashbourne Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
101193001000001112 Ebesque XL 400mg tablets (Ethypharm UK Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ebesque XL 400mg tablets (DB Ashbourne Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Ebesque XL 400mg tablets (DB Ashbourne Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ebesque XL 400mg tablets (DB Ashbourne Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Ebesque XL 400mg tablets (DB Ashbourne Ltd) Is a Product containing precisely quetiapine (as quetiapine fumarate) 400 milligram/1 each prolonged-release oral tablet true Inferred relationship Existential restriction modifier
Ebesque XL 400mg tablets (DB Ashbourne Ltd) Has active ingredient Quetiapine false Inferred relationship Existential restriction modifier
Ebesque XL 400mg tablets (DB Ashbourne Ltd) Has manufactured dose form Extended-release tablet false Inferred relationship Existential restriction modifier
Ebesque XL 400mg tablets (DB Ashbourne Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ebesque XL 400mg tablets (DB Ashbourne Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Ebesque XL 400mg tablets (DB Ashbourne Ltd) Has specific active ingredient Quetiapine fumarate true Inferred relationship Existential restriction modifier
Ebesque XL 400mg tablets (DB Ashbourne Ltd) Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Ebesque XL 400mg tablets (DB Ashbourne Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Quetiapine true Inferred relationship Existential restriction modifier
Ebesque XL 400mg tablets (DB Ashbourne Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Ebesque XL 400mg tablets (DB Ashbourne Ltd) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Ebesque XL 400mg tablets (DB Ashbourne Ltd) Is a Ebesque XL true Inferred relationship Existential restriction modifier
Ebesque XL 400mg tablets (DB Ashbourne Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Ebesque XL 400mg tablets (DB Ashbourne Ltd) Has basis of strength substance Quetiapine true Inferred relationship Existential restriction modifier
Ebesque XL 400mg tablets (DB Ashbourne Ltd) Has manufactured dose form Prolonged-release oral tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Ebesque XL 400mg tablets (DB Ashbourne Ltd) 60 tablet 6 x 10 tablets Has AMP True Ebesque XL 400mg tablets (DB Ashbourne Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start